Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II trial of ACYW135 meningococcal polysaccharide conjugate vaccine in participants aged 3 months to 15 years
CTR20240824Phase 2Active
- Sponsor
- AIM Vaccine Co., Ltd.
- Start
- Mar 2024
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of A, C, Y, W135 meningococcal polysaccharide vaccine in meningococcal disease, meningococcal meningitis, sponsored by AIM Vaccine Co., Ltd.. Started Mar 2024; status: active.
02
Drugs
A, C, Y, W135 meningococcal polysaccharide vaccine
03
Conditions
meningococcal diseasemeningococcal meningitis
Beyond the preview
Go deeper on CTR20240824.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20240824.